This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Explorna Therapeutics Sp. Z O.O., Uniwersytet Warszawski. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 3 Years Active: 2026
Title: Marcin Warminski: Inventor in RNA Technology.
Introduction
Marcin Warminski is an inventor based in Warszawa, Poland. His work includes research on modified mRNA cap analogs and their potential applications in RNA synthesis and peptide production.
Latest Patents
Warminski is associated with 1 patent: “Novel mRNA 5′-End Cap Analogs Modified Within Phosphate Residues, RNA Molecule Incorporating the Same, Uses Thereof and Method of Synthesizing RNA Molecule or Peptide.” The invention concerns modified phosphate residues in mRNA cap analogs and describes related RNA molecules, uses, and synthesis methods.
Career Highlights
Warminski is associated with Uniwersytet Warszawski and Explorna Therapeutics Sp. z o.o. These affiliations connect his work with academic research and biotechnology.
Collaborations
His listed coworkers include Pawel Sikorski and Joanna Kowalska. Their shared work is associated with research and development in RNA-related technologies.
Conclusion
Marcin Warminski’s patent activity centers on modified mRNA cap analogs, reflecting an interest in RNA synthesis and its potential applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile